Das, Nando D.
Chang, Jen-Chien
Hon, Chung-Chau
Kelly, S. Thomas http://orcid.org/0000-0003-3904-6690
Ito, Shinsuke
Lizio, Marina
Kaczkowski, Bogumil
Watanabe, Hisami
Katsushima, Keisuke
Natsume, Atsushi
Koseki, Haruhiko
Kondo, Yutaka
Minoda, Aki
Umehara, Takashi
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP21K06028, JP19H05745, JP16H05089)
Japan Agency for Medical Research and Development (AMED-CREST, 13417643, 19cm0106108h0004, 19cm0106108h0004)
Japan Science and Technology Agency (JPMJPR12A3)
Article History
Received: 26 July 2023
Accepted: 7 September 2023
First Online: 27 September 2023
Declarations
:
: All methods of this study using human subjects were conducted in accordance with the ‘Ethical Guidelines for Medical and Biological Research Involving Human Subjects’ of Japan under the approval of RIKEN (approval no. H28-3) and Nagoya University (approval no. 2012–0067). Informed consent was obtained from all participants included in this study.
: Consent for publication of anonymized personal information was obtained from all participants.
: BK took a position with AstraZeneca R&D during the submission of this manuscript. AstraZeneca R&D was not involved at any stage of the work presented here and there is no conflict of interest related to AstraZeneca R&D for this work. BK may own stock options of AstraZeneca. The authors declare no competing interests.